Managing Insomnia: A Primary Care Perspective

Please read through the following information and click the appropriate link at the bottom of the page.

Release and Expiration Date

Release Date: June 1, 2006
Expiration Date: June 1, 2008

Target Audience

The program is targeted towards primary care physicians, internists, psychiatrists and other healthcare professional involved in the management of insomnia.

Program Description

This is a one hour program, which has been designed to educate primary care professionals about the latest updates in the management of insomnia. Leading sleep and family practice experts use case presentation and discussion to explain how to overcome barriers to the effective management of this condition and to provide pearls for the diagnosis and treatment of this under-recognized condition. Following successful of completion of the program, 1 hour of CME credit will be awarded.

Educational Objectives

Upon completion of this program the participant should be able to:

• Define and classify insomnia
• Explain how to recognize and manage insomnia
• List consequences of inadequately managed insomnia
• Discuss what studies are needed to better understand insomnia and its management

Accreditation Statement

This activity has been reviewed and is acceptable for up to 1 Prescribed credit(s) by the American Academy of Family Physicians. Term of approval is for one year from beginning distribution date of 6/1/06, with option for yearly renewal.

AAFP Prescribed credit is accepted by the American Medical Association as equivalent to AMA PRA category 1 credit toward the AMA Physician's Recognition Award. When applying for the AMA PRA, Prescribed credit earned must be reported as Prescribed credit, not as category 1.

Faculty Information

Terry E. Shlimbaum, MD
Clinical Assistant Professor
UMDNJ-Robert Wood Johnson Medical Center, New Jersey

Richard Simon, MD
Medical Director, Kathryn Severyns Dement Sleep Disorders Center
St. Mary Medical Center, Washington

Joyce Walsleben, PhD
Director, Sleep Disorders Center
New York University School of Medicine, New York

Instructions

To receive a statement of credit for up to 1 credit, you must:

• Review the entire activity
• Reflect on the content
• Successfully complete the post-test with a score of 70% or higher
• Complete the evaluation form and follow the directions to receive your certificate of credit

Fee

There is no fee for this program.

Commercial Support

This program is supported through an educational grant from sanofi-aventis U.S. Inc.

Faculty Disclosures

The New Jersey Academy of Family Physicians adheres to the conflict-of-interest policy of the American Academy of Family Physicians as well as to the guidelines of the Accreditation Council for Continuing Medical Education and the AMA. Current guidelines state that participants in CME activities should be made aware of any affiliation or financial interest that may affect a presenter. The members of this program have completed conflict-of-interest statements. Disclosures do not suggest bias, but provide viewers with information relevant to the evaluation of the content of these guidelines.

Richard Simon, MD has received grant or research support from the NIH and has acted as a consultant for Merck & Co., Inc.

Terry Shlimbaum, MD has disclosed that he has no relevant financial relationships with any commercial interests related to the content of this educational activity.

Joyce Walsleben, PhD received grant or research support from Cephalon, and Orphan/JAZZ, has acted as a consultant and received honorarium from Cephalon, Sanofi-Aventis, Sepracor, Orphan, Serta and Takeda

It is the policy of the accreditors to ensure independence, balance, objectivity, scientific rigor, and integrity in all of their continuing education activities.

Unlabeled Use Disclosure

The author, sponsor, and publisher of this continuing education activity have made all reasonable efforts to ensure that information contained herein is accurate in accordance with the latest available scientific knowledge at the time of accreditation. Information regarding drugs (e.g. their administration, dosages, contraindications, adverse reactions, interactions, special warning, precautions) and drug delivery systems is subject to change, however, and the reader is advised to check the manufacturer's package insert for information concerning recommended dosage and potential problems or cautions prior to dispensing or administering the drug or using the drug delivery system.

The faculty have indicated that there will be discussion of unapproved uses in their presentations.

Sponsored by:

Software Requirements

Flash Player Plugin (v6.079 or greater)
Adobe Acrobat Reader
Internet Explorer (5.5 or greater) or Netscape (v7.02 or greater)
Internet Explorer is not supported on the Macintosh.
Windows 98 SE or above